Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (6998)	1/8/2001 1:43:54 PM
From: Toby Zidle	Read Replies (1) \| Respond to of 17683

Rick, aren't you getting a bit defensive here? My post to you wasn't a flame. "Why should I comment on a comment that is irrelevant to my post?" Because that comment IS your post. #6979 "Most of the components in ^BTK are "operational", and therefore differ from the vast majority of companies in the "biotech sector"." Then and now you give me an impression that I should be finding companies like MRK, PFE, LLY, JNJ in the ^BTK. These are the operational companies that are not representative of the "biotech sector". When I tracked down the components of ^BTK, I found: ATIS, AMGN, BTGC, BGEN, CEPH, CHIR, CORR, GENZ, GILD, IMNR, IMNX, MEDI, ORG, and PDLI. How are most of these "operational" (as the pharmaceuticals are)? I think the spectrum of companies here from AMGN to ATIS is very representative of a broad research "biotech" sector. My prior posting was simply asking you to clarify your original thought that " ^BTK is ... an average of mostly OPERATIONAL companies, not research boutiques. These companies produce DRUGS, and are therefore relatively recession-strong. The index does NOT represent the biotech sector as a whole" It still looks like you were talking about ^DRG, not ^BTK. "Teach him what ^BTK is," you'd said to Bill G. Well, you've yet to teach me anything about the ^BTK. If you prefer not to discuss this further, that is all right with me.